These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [Pulmonary alveolar proteinosis: a disease caused by surfactant accumulation, and new treatment with sargramostim]. Huisman P; Grutters JC; van den Bosch JM Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1450-4. PubMed ID: 18666660 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary alveolar proteinosis. What is the role of GM-CSF in disease pathogenesis and treatment? Seymour JF; Presneill JJ Treat Respir Med; 2004; 3(4):229-34. PubMed ID: 15350161 [No Abstract] [Full Text] [Related]
17. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor. Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies. Khan A; Agarwal R; Aggarwal AN Chest; 2012 May; 141(5):1273-1283. PubMed ID: 22016491 [TBL] [Abstract][Full Text] [Related]